Soliel Securities initiates coverage on Bristol-Myers Squibb (NYSE: BMY) with a 'Hold' rating and $28 price target.
...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE